Trial Profile
Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2017
Price :
$35
*
At a glance
- Drugs Clonidine (Primary)
- Indications Pervasive child development disorders
- Focus Therapeutic Use
- 31 Jan 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2017.
- 31 Jan 2017 Planned initiation date changed from 1 Jul 2016 to 1 Aug 2016.
- 31 Jan 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.